Stockscreener 앱 받기
54.08
3.36%
-1.88
시간 외 거래:
54.08
Vaxcyte Inc 주식(PCVX)의 최신 뉴스
Grant Pickering (PCVX) outlines 18,198-share sale and recent June stock trades - Stock Titan
PCVX|Vaxcyte Inc|Price:55.720|Chg%:+1.060 - TradingKey
Vaxcyte Inc (PCVX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vaxcyte Inc (PCVX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TradingKey - TradingKey
Vaxcyte Inc (PCVX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vaxcyte Inc (PCVX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vaxcyte Inc (PCVX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vaxcyte Inc (PCVX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Vaxcyte Inc (PCVX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PCVX|Vaxcyte Inc|Price:55.535|Chg%:+0.875 - TradingKey
Is Vaxcyte's VAX-31 a Game-Changer in the Vaccine Landscape - Kavout | AI
Enterprise value to revenue forward of Vaxcyte, Inc. – BX:PCVX - TradingView
Vaxcyte, Inc. Revenue Breakdown – NASDAQ:PCVX - TradingView
ETFs Investing in Vaxcyte, Inc. Stocks - TradingView
Vaxcyte: Clinical-Stage Vaccine Disrupter With Vast Near-Term Potential - Seeking Alpha
Vaxcyte stock consolidates after raising fresh capital and advancing PCVX vaccine pipeline - Ad-hoc-news.de
MSN Money - MSN
Why (PCVX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Vaxcyte Director John Markels Awarded 23,029 Stock Options in July 2026 Equity Grant - Kalkine Media
Form 4 Vaxcyte Inc For: 16 July By Investing.com - Investing.com Nigeria
Vaxcyte, Inc. (PCVX) awards 23,029 stock options to director John Markels - Stock Titan
Vaxcyte, Inc. (PCVX) director files Form 3 reporting zero holdings - Stock Titan
Vaxcyte (NASDAQ: PCVX) adds independent director John Markels, sets $430,000 equity grant - Stock Titan
Guggenheim Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $116 - Moomoo
Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring an 87% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
Vaxcyte Inc. (PCVX) Slides 2.71%, Approaches Key Support at $55.3IV Spike - dars.gov.et
Vaxcyte Inc. (PCVX) Sees Modest Pullback After Recent Rally – Key Support Levels in FocusMcClellan Oscillator - dars.gov.et
Vaxcyte to Participate in Upcoming Investor Conferences - Investing News Network
Vaxcyte Inc develops next-generation vaccines as interest in pneumococcal prevention grows - ad-hoc-news.de
Should Early VAX-A1 Trial Progress Require Action From Vaxcyte (PCVX) Investors? - simplywall.st
Vaxcyte Inc. (PCVX) Surges 6.5% as Vaccine Developer Attracts Renewed Investor InterestIceberg Order - dars.gov.et
Vaxcyte COO Jim Wassil sells $126,736 in PCVX shares By Investing.com - Investing.com Australia
Vaxcyte president and CFO sells $572k in company stock By Investing.com - Investing.com Australia
Vaxcyte president and CFO sells $572k in company stock - Investing.com
Form 4 Vaxcyte Inc For: 6 July By Investing.com - Investing.com Nigeria
[Form 4] Vaxcyte, Inc. Insider Trading Activity - Stock Titan
Vaxcyte COO Jim Wassil sells $126,736 in PCVX shares - Investing.com
Vaxcyte (PCVX) COO logs 2,250-share sale and option exercise in Form 4 - Stock Titan
Affiliate plans 10,000-share sale by option exercise — PCVX - Stock Titan
Vaxcyte, Inc. (PCVX) Stock Analysis: Biotechnology Innovator with an 86.68% Potential Upside - DirectorsTalk Interviews
PCVXVaxcyte Inc Volatility & Greeks - Finviz
Vaxcyte stock stays tied to pipeline progress. Nasdaq listing and SEC filings frame the setup. - Ad-hoc-news.de
Vaxcyte Inc (PCVX) Is A Hidden Multibagger Stock To Buy Now - Yahoo Finance
Vaxcyte Inc. (PCVX) Surges 4% as Vaccine Developer Gains MomentumGap Down Bounce Plays - dars.gov.et
Have Insiders Sold Vaxcyte Shares Recently? - simplywall.st
2.44%
0.02%
자본화:
|
볼륨(24시간):